Abbott Laboratories
SWB:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
SWB:ABL
|
US |
|
Essity AB (publ)
F:ESWB
|
SE |
|
D
|
Discover Financial Services
SWB:DC7
|
US |
|
V
|
Valeura Energy Inc
F:83PN
|
CA |
|
H
|
Healthcare Realty Trust Inc
F:HR6
|
US |
|
F
|
Fiserv Inc
F:FIV
|
US |
|
A
|
Atoss Software AG
DUS:AOF
|
DE |
|
C
|
Compass Minerals International Inc
F:CM8
|
US |
|
C
|
Cigna Corp
XHAM:CGN
|
US |
|
Mirait One Corp
F:5FO
|
JP |
|
S
|
Singapore Airlines Ltd
XMUN:SIA1
|
SG |
|
W
|
Williams-Sonoma Inc
XMUN:WM1
|
US |
|
U
|
Union Pacific Corp
XMUN:UNP
|
US |
|
Hamborner REIT AG
OTC:HMBRF
|
DE |
|
D
|
Dave & Buster's Entertainment Inc
F:9DB
|
US |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 102.18 EUR with a low forecast of 77.8 EUR and a high forecast of 125.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
102.18
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 102.18 EUR with a low forecast of 77.8 EUR and a high forecast of 125.71 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.
